Curcumin attenuates diabetic neuropathic pain by downregulating TNF-α in a rat model

International Journal of Medical Sciences

Volumn 10, Issue 4, 2013, Pages 377-381

  Li, Yue ^a   Zhang, Yong ^b,c   Liu, De Bao ^a   Liu, Hai Ying ^a   Hou, Wu Gang ^c   Dong, Yu Shu ^a  

^a The 463 Hospital of Chinese PLA   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic neuropathic pain; Hyperalgesia; curcumin; tumour necrosis factor tumour necrosis factor receptor 1

Indexed keywords

CURCUMIN; GLUCOSE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOWN REGULATION; GLUCOSE BLOOD LEVEL; HYPERALGESIA; HYPERSENSITIVITY; MALE; NONHUMAN; RAT; SPINAL CORD DORSAL HORN; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

CURCUMIN; DIABETIC NEUROPATHIC PAIN; HYPERALGESIA; TUMOUR NECROSIS FACTOR Α; TUMOUR NECROSIS FACTOR Α RECEPTOR 1.;

ANIMALS; BLOOD GLUCOSE; CURCUMIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; HYPERALGESIA; MALE; NEURALGIA; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874784858     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5224     Document Type: Article

References (23)

1. Yagihashi S, Yamagishi S, Wada R. Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms. Diabetes Res Clin Pract 2007; 77 Suppl 1: S184-S189.
2. Al-Nimer MS, Al-Ani FS, Ali FS. Role of nitrosative and oxidative stress in neuropathy in patients with type 2 diabetes mellitus. J Neurosci Rural Pract 2012; 3: 41-44.
3. Green CJ, Pedersen M, et al. Elevated NF-kappaB activation is conserved in human myocytes cultured from obese type 2 diabetic patients and attenuated by AMP-activated protein kinase. Diabetes 2011; 60: 2810-2819.
4. Newsholme P, Gaudel C, Krause M. Mitochondria and diabetes. An intriguing pathogenetic role. Adv Exp Med Biol 2012; 942: 235-247.
5. Rodrigues AM, Bergamaschi CT, Araujo RC, et al. Effects of training and nitric oxide on diabetic nephropathy progression in type I diabetic rats. Exp Biol Med (Maywood) 2011; 236: 1180-1187.
6. Zhang YL, Xu JM, Zhou P, et al. Distinct activation of tumor necrosis factor-alpha and interleukin-6 in the spinal cord after surgical incision in rats. Mol Med Report 2012; 5: 1423-1427.
7. Tumati S, Largent-Milnes TM, Keresztes A, et al. Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist. J Neuroimmunol 2012; 244: 23-31.
8. Wen YR, Tan PH, Cheng JK, et al. Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance. J Formos Med Assoc 2011; 110: 487-494.
9. Jung WW, Kim HS, Shon JR, et al. Intervertebral disc degeneration- induced expression of pain-related molecules: glial cell-derived neurotropic factor as a key factor. J Neurosurg Anesthesiol 2011; 23: 329-334.
10. Gao X, Kuo J, Jiang H, et al. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol 2004; 68: 51-61.
11. Adeghate E, Parvez SH. Nitric oxide and neuronal and pancreatic beta cell death. Toxicology 2000; 153: 143-156.
12. Mythri RB, Bharath MM. Curcumin: a potential neuroprotective agent in Parkinson's disease. Curr Pharm Des 2012; 18: 91-99.
13. Pittenger GL, Malik RA, Burcus N, et al. Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes. Diabetes Care 1999; 22: 1839-1844.
14. Andrade P, Visser-Vandewalle V, Del RJ, et al. The thalidomide analgesic effect is associated with differential TNF-alpha receptor expression in the dorsal horn of the spinal cord as studied in a rat model of neuropathic pain. Brain Res 2012; 1450: 24-32.
15. Choi JI, Svensson CI, Koehrn FJ, et al. Peripheral inflammation induces tumor necrosis factor dependent AMPA receptor trafficking and Akt phosphorylation in spinal cord in addition to pain behavior. Pain 2010; 149: 243-253.
16. Spicarova D, Nerandzic V, Palecek J. Modulation of spinal cord synaptic activity by tumor necrosis factor alpha in a model of peripheral neuropathy. J Neuroinflammation 2011; 8: 177.
17. Leung L, Cahill CM. TNF-alpha and neuropathic pain--a review. J Neuroinflammation 2010; 7: 27.
18. Zhang L, Berta T, Xu ZZ, et al. TNF-alpha contributes to spinal cord synaptic plasticity and inflammatory pain: distinct role of TNF receptor subtypes 1 and 2. Pain 2011; 152: 419-427.
19. Nishida M, Nishiumi S, Mizushina Y, et al. Monoacetylcurcumin strongly regulates inflammatory responses through inhibition of NF-kappaB activation. Int J Mol Med 2010; 25: 761-767.
20. Park CK, Lu N, Xu ZZ, et al. Resolving TRPV1- and TNF-alpha-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J Neurosci 2011; 31: 15072-15085.
21. Sharma S, Kulkarni SK, Agrewala JN, et al. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pharmacol 2006; 536: 256-261.
22. Sharma S, Chopra K, Kulkarni SK. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother Res 2007; 21: 278-283.
23. Huang G, Yang Y, Xu Z, et al. Downregulation of B lymphocyte stimulator expression by curcumin in B lymphocyte via suppressing nuclear translocation of NF-kappaB. Eur J Pharmacol 2011; 650: 451-457.